Investor Presentaiton

Sartorius Group Track record of dynamic growth; balanced regional revenue profile BPS sales revenue; EBITDA margin¹ in % CAGR² 18% ~€1.14bn 28.6 ~€2.68bn Pillars of growth CAGRS 2022-20271 Pharma market -3-6% Biopharma market -10% Y Biosimilars -15% 핫 CGT -20% 29.2 2018 Sales revenue 2019 2020 2021 2022 2023 EBITDA¹ margin in % 1 Excluding extraordinary items 2 In constant currencies 17 Single-use ~15% SARTORIUS

View entire presentation